טוען...
Spotlight on itolizumab in the treatment of psoriasis – current perspectives from India
Psoriasis is a chronic, debilitating, immune-mediated, systemic inflammatory disease affecting mainly skin, nails, and joints. Several therapeutic modalities are available depending on the severity of the disease. Long-term use of these drugs results in unwanted effects and toxicities. Recently, ito...
שמור ב:
| הוצא לאור ב: | Psoriasis (Auckl) |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6501705/ https://ncbi.nlm.nih.gov/pubmed/31119094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PTT.S154073 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|